Sunday, 19 September 2021

 

 

NEWS FLASH Tourist Places of Kashmir : Betaab Valley Also known as Switzerland of India JK coming up as golfing capital of the country : Sarmad Hafeez Dr. Jitendra Singh conducts extensive tour of Khonmoh, Srinagar Good Health and Development Go Hand in Hand : Mansukh Mandaviya Lt Governor hands over Individual and Community Forest Rights certificates to members of Tribal Communities of Jammu Division Former legislators call on Lt Governor, highlight issues of public importance Lt Governor, Manoj Sinha honours Tokyo Paralympics Participants J&K JA organizes training on “Personality Development, a Pursuit of Justice, Leadership role of a Judge as captain of ship in Trial Court” Promoting Paradise : Srinagar hosts Lions Club MICE event Roll Ball Association delegation calls on Advisor Farooq Khan DDC Chairperson Udhampur gives away motorised tricycles to specially abled persons Deputy Commissioner Udhampur, Indu Kanwal Chib listens to issues of local artisans at Panchayat Sansoo J&K Bank CMD meets PHDCCI delegation First ever coordination meeting held at District Court Complex Ganderbal Fit India Movement : DC Ramban flags off Patnitop Hill Marathon DC Ganderbal inspects progress on various School Education projects DDC Anantnag , Dr. Piyush Singla inaugurates inter-zonal tournaments Divisional Commissioner Kashmir, Pandurang Kondbara Pole for 100% vaccination of staff in govt, private offices Divisional Commissioner Kashmir, Pandurang Kondbara Pole conducts site visit of Srinagar riverfront project Divisional Commissioner Kashmir, Pandurang Kondbara Pole invokes Imams, Khateebs for CAB enforcement in Srinagar DC Kupwara, Imam Din visits fire victims at Nagri Malpora

 

Covid jabs won't raise immunity in organ transplant patients: Study

Coronavirus, COVID 19, Novel Coronavirus, Covaxin, Covishield, Covid-19 Vaccine, COVID-19 Vaccination, COVID Vaccination, Coronavirus Vaccine, Oxygen, #OxygenCylinders, #oxygen, Oxygen Cylinders, SARS-CoV-2, Health, Study, New York, Research, Researchers, World News, Journal of the American Medical Association, JAMA

Web Admin

Web Admin

5 Dariya News

New York , 09 May 2021

Patients, who had organ transplants, remain vulnerable to Covid-19 infections even after a second vaccine dose, finds a study that urges people who are immunocompromised to strictly adhere to wearing masks, and maintain physical distancing, even after vaccination.The study, led by researchers at Johns Hopkins University in the US, showed that after two doses of Moderna or Pfizer-BioNTech vaccine against SARS-CoV-2 -- the virus that causes Covid 19, just 54 per cent people who have received solid organ transplants produced sufficient antibodies. The findings are published in the Journal of the American Medical Association (JAMA)."Transplant recipients should not assume that two vaccine doses guarantee sufficient immunity against SARS-CoV-2 any more than it did after just one dose," said Dorry Segev, Professor of Surgery and Epidemiology at the Johns Hopkins School of Medicine."Based on our findings, we recommend that transplant recipients and other immunocompromised patients continue to practice strict Covid-19 safety precautions, even after vaccination," added lead author Brian Boyarsky, surgeon at the varsity.

People who receive solid organ transplants (such as hearts, lungs and kidneys) often must take drugs to suppress their immune systems and prevent rejection. Such regimens may interfere with a transplant recipient's ability to make antibodies to foreign substances, including the protective ones produced in response to vaccines, the researchers said.The study evaluated this immunogenic response following vaccination from either Moderna or Pfizer-BioNTech in 658 transplant recipients, none of whom had a prior diagnosis of Covid-19, between December 16, 2020, and March 13, 2021.The team found that only 98 of the 658 study participants -- 15 per cent -- had detectable antibodies to SARS-CoV-2 at 21 days after the first vaccine dose.At 29 days following the second dose, the number of participants with detectable antibodies rose to 357 out of 658 -- 54 per cent. After both vaccine doses were administered, 301 out of 658 participants -- 46 per cent -- had no detectable antibody at all while 259 -- 39 per cent -- only produced antibodies after the second shot.

 

Tags: Coronavirus , COVID 19 , Novel Coronavirus , Covaxin , Covishield , Covid-19 Vaccine , COVID-19 Vaccination , COVID Vaccination , Coronavirus Vaccine , Oxygen , #OxygenCylinders , #oxygen , Oxygen Cylinders , SARS-CoV-2 , Health , Study , New York , Research , Researchers , World News , Journal of the American Medical Association , JAMA

 

 

related news

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
Copyright 2011-2021 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD